Columbia Laboratories Inc.  

(Public, NASDAQ:CBRX)   Watch this stock  
Find more results for Valerie D. Jones�
5.92
-0.06 (-1.00%)
Real-time:   1:59PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.92 - 5.97
52 week 5.59 - 7.56
Open 5.97
Vol / Avg. 8,845.00/30,291.00
Mkt cap 64.20M
P/E 22.04
Div/yield     -
EPS 0.27
Shares 10.77M
Beta 0.74
Inst. own 18%
Sep 9, 2014
Columbia Laboratories Inc at Rodman & Renshaw Global Investment Conference
Jul 31, 2014
Q2 2014 Columbia Laboratories Earnings Release
Jul 31, 2014
Q2 2014 Columbia Laboratories Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 2.81% 22.94%
Operating margin 4.11% 20.10%
EBITD margin - 28.80%
Return on average assets 1.48% 13.83%
Return on average equity 1.88% 17.07%
Employees 77 -
CDP Score - -

Address

4TH FLOOR, 4 LIBERTY SQUARE
BOSTON, MA 2109
United States - Map
+1-973-4868820 (Phone)
+1-617-4820618 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Columbia Laboratories, Inc. (Columbia) is engaged in pharmaceutical development. The Company has developed and brought to market six bioadhesive products, each commercialized through alliances. The Company�s product, CRINONE (progesterone gel), is sold by Actavis in the United States and by Merck Serono in over 60 other countries worldwide. In September 2013, Columbia acquired Molecular Profiles, a CDMO. Through Molecular Profiles, the Company offers formulation, development, manufacturing and analytics capabilities to clients, including multi-national pharmaceutical companies, specialized drug-delivery firms and biotechnology companies.

Officers and directors

Stephen Garfield Kasnet Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Frank C. Condella Jr. President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Jonathan B. Lloyd Jones Chief Financial Officer, Vice President, Treasurer, Secretary
Age: 53
Bio & Compensation  - Reuters
Donald H. Hunter Director
Age: 58
Bio & Compensation  - Reuters
Nikin Patel Director
Age: 41
Bio & Compensation  - Reuters
Valerie L. Andrews Independent Director
Age: 54
Bio & Compensation  - Reuters
Frank Murdoch Armstrong Independent Director
Age: 56
Bio & Compensation  - Reuters
Cristina Csimma Pharm.D., M.H.P. Independent Director
Age: 55
Bio & Compensation  - Reuters